Effects of Mannitol 20% on Outcomes in Nontraumatic Intracerebral Hemorrhage

Document Type : Original Article

Authors

Department of Neurosurgery, Al-Zahra Hospital, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Background: A large number of stroke patients are not the perfect candidate for craniotomy and invasive procedures, so providing an alternative and noninvasive method, which is applicable in terms of costs and facilities, is necessary. Thus, the present study aimed to determine the effects of mannitol 20% on outcome of the patients with nontraumatic intracerebral hemorrhage (ICH) in patients admitted to Isfahan's Al-Zahra Hospital during 2012 and 2013. Materials and Methods: This is a clinical trial study which is conducted during 2012–2013 in Isfahan's Al-Zahra Hospital. In this study, 41 patients suffering from ICH received mannitol 20% for 3 days, and volume of hemorrhage and Glasgow Coma Scale (GCS) of patients were controlled every 12 h. The collected data were analyzed via SPSS software. Results: The mean ICH volume was 22.1 ± 6.3 ml in pre intervention and 38.4 ± 19.3 ml in post intervention, and according to the t-paired test, before and after treatment the difference was significant (P < 0.001). Hemorrhage volume was stable in nine patients (22%), it increased in 25 patients (61%), and decreased in seven patients (17.1%). The mean index of GCS before and after treatment was 11.85 ± 1.6 and 9.37 ± 2.65, respectively. Moreover according to t-paired test, the difference was significant before and after treatment (P < 0.001). During using mannitol, the GCS index was stable in eight patients (19.5%), it increased in eight patients (19.5%) and decreased in 25 patients (61%). Conclusions: Mannitol injection was not effective in reducing hemorrhage size, and its use is not recommended, also, further studies in this field have been proposed.

Keywords

1.
Pascual AM, López-Mut JV, Benlloch V, Chamarro R, Soler J, Láinez MJ. Perfusion-weighted magnetic resonance imaging in acute intracerebral hemorrhage at baseline and during the 1st and 2nd week: A longitudinal study. Cerebrovasc Dis 2007;23:6-13.  Back to cited text no. 1
    
2.
Sacco RL, Mayer SA. Epidemiology of intracerebral hemorrhage. In: Feldmann E, editor. Intracerebral Hemorrhage. Armonk, New York: Futura Publishing Co.; 1994. p. 3-23.  Back to cited text no. 2
    
3.
Brouwers HB, Chang Y, Falcone GJ, Cai X, Ayres AM, Battey TW, et al. Predicting hematoma expansion after primary intracerebral hemorrhage. JAMA Neurol 2013;23:1001-9.  Back to cited text no. 3
    
4.
Thapa LJ, Shrestha A, Pokhrel B, Poudel R, Rana PV. Stroke mortality in intensive care unit from tertiary care neurological center. JNMA J Nepal Med Assoc 2013;52:332-6.  Back to cited text no. 4
    
5.
Ziai WC, Melnychuk E, Thompson CB, Awad I, Lane K, Hanley DF. Occurrence and impact of intracranial pressure elevation during treatment of severe intraventricular hemorrhage. Crit Care Med 2012;40:1601-8.  Back to cited text no. 5
    
6.
Corral L, Ventura JL, Herrero JI, Monfort JL, Juncadella M, Gabarrós A, et al. Improvement in GOS and GOSE scores 6 and 12 months after severe traumatic brain injury. Brain Inj 2007;21:1225-31.  Back to cited text no. 6
    
7.
Khurram A, Kleinig T, Leyden J. Clinical associations and causes of convexity subarachnoid hemorrhage. Stroke 2014;4:1224-9.  Back to cited text no. 7
    
8.
Abrignani MG, Colivicchi F. Thromboembolic and hemorrhagic risk stratification in patients with atrial fibrillation. Part I: The thromboembolic risk. Monaldi Arch Chest Dis 2013;80:60-5.  Back to cited text no. 8
    
9.
Wang HK, Tsai KJ, Huang CY, Wang LC, Lu K, Chen HJ, et al. Newly diagnosed dementia and increased risk of hemorrhagic stroke. Curr Alzheimer Res 2014;31:45-9.  Back to cited text no. 9
    
10.
Caglar NS, Akin T, Erdem IH, Ozgonenel L, Aytekin E, Tutun S, et al. Where are we in terms of poststroke functional outcomes and risk factors. NeuroRehabilitation 2014;28:58-60.  Back to cited text no. 10
    
11.
Ye H, Su Y. Hemodynamic effects of mannitol infusion in patients with acute intracerebral hemorrhage. Acta Cir Bras 2013;28:106-11.  Back to cited text no. 11
    
12.
Vicenzini E, Ricciardi MC, Zuco C, Sirimarco G, Di Piero V, Lenzi GL. Effects of a single mannitol bolus on cerebral hemodynamics in intracerebral hemorrhage: A transcranial Doppler study. Cerebrovasc Dis 2011;32:447-53.  Back to cited text no. 12
    
13.
Kumar S, Badrinath HR. Early recombinant factor VIIa therapy in acute intracerebral hemorrhage: Promising approach. Neurol India 2006;54:24-7.  Back to cited text no. 13
[PUBMED]  [Full text]  
14.
Werneck LC, Scola RH, Ferraz LE. Spontaneous intracerebral hematomas: Study of 121 cases. Arq Neuropsiquiatr 1991;49:18-26.  Back to cited text no. 14
    
15.
Francony G, Fauvage B, Falcon D, Canet C, Dilou H, Lavagne P, et al. Equimolar doses of mannitol and hypertonic saline in the treatment of increased intracranial pressure. Crit Care Med 2008;36:795-800.  Back to cited text no. 15
    
16.
Rosenfeld DM, Trentman T, Patel NP. Pontine hemorrhage following a recently implanted intrathecal drug delivery system. Pain Pract 2009;9:312-6.  Back to cited text no. 16
    
17.
Misra UK, Kalita J, Vajpayee A, Phadke RV, Hadique A, Savlani V. Effect of single mannitol bolus in intracerebral hemorrhage. Eur J Neurol 2007;14:1118-23.  Back to cited text no. 17
    
18.
Chen YC, Sun CA, Yang T, Chu CH, Bai CH, You SL, et al. Impact of metabolic syndrome components on incident stroke subtypes. J Hum Hypertens 2014;16:152-9.  Back to cited text no. 18
    
19.
Stone JJ, Childs S, Smith LE, Battin M, Papadakos PJ, Huang JH. Hourly neurologic assessments for traumatic brain injury in the ICU. Neurol Res 2014;36:164-9.  Back to cited text no. 19
    
20.
Richard W. Youmans Neurological Surgery. 6th ed. Philadelphia: Elzevier Corp.; 2011. p. 3428-70.  Back to cited text no. 20
    
21.
Rowland LP. Merits Neurology. 12th ed. Philadelphia: Lippincott Williams and Wilkins,; 2010. p. 278-9.  Back to cited text no. 21
    
22.
Greenberg MS. Handbook of Neurosurgery. 7th ed. New York: Theme Corp.; 2010. p. 877.  Back to cited text no. 22
    
23.
Sharaz S, Ghaziani T. Handbook of Iran Pharma. 2nd ed. Tehran: Teymourzadeh Corp.; 2008. p. 373.  Back to cited text no. 23
    
24.
Prakash ES. Is the use of hypertonic mannitol appropriate in the management of intracerebral hemorrhage? Stroke 2008;39:e85.  Back to cited text no. 24
    
25.
Misra UK, Kalita J, Ranjan P, Mandal SK. Mannitol in intracerebral hemorrhage: A randomized controlled study. J Neurol Sci 2005;234:41-5.  Back to cited text no. 25
    
26.
Bereczki D, Liu M, do Prado GF, Fekete I. Mannitol for acute stroke. Stroke 2008;39:512-3.  Back to cited text no. 26